FDA Investigator Kirk A Dymbrowski

Kirk A Dymbrowski has inspections in 3 countries as of 18 Sep 2023. Kirk A Dymbrowski has collaborated with a combinined 3239 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
256
Last Inspection Date:
18 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Japan
Co-Investigator(s):
Alan Escalona, Alec M O'neal, Allison C Hunter, Allison E Sincek, Allison M Mcgloin, Amanda M Osteen, Amber G Chung, Amber I Jessup, Amy L Mccarthy, Anastasia M Shields, Andrew I Carr, Andrew J Barrowcliff, Andrew J Lang, Andrew M Kupper, Andria L Kuhlman, Annemarie Kleiza, Arie R Dyk, Ashley M Whitehurst, Ashley R Karns, Bailey A Uetrecht, Benjamin P Stewart, Brandi L Garbutt, Brandon J Brookens, Brandon M Kurjanowicz, Brant M Schroeder, Brian M Palermo, Brian P Hendrickson, Brian R Yaun, Carl E Lovrich, Carlos Hruiz Nunez, Carrie L Doupnik, Catherine D Djordjevic, CDR Michael J Mero, Cecil D Mitchell, Chamberlain, Charlean R Butler, Charles C Conn, III, Charles E Idjagboro, Christian L Witkovskic, Christian L Witkovskie, Christopher D Snyder, Clara E Santiago, Craig P Seaborn, Craig Seaborn, Craig T Rybus, Crayton Lee, Cynthia L Rakestraw, Cynthia T Cain, Darren S Morgan, Dauksism, David L Chon, David L Craft, David P Moorhead, Dell S Moller, Denise R Pinkerton, Dennis L Doupnik, Dennis R Hock, Dessa A Antoine, Diane M Fresch, Diane R Mcdaniel, Dianne H Milazzo, Dorathy M Eischen, Dougherty, Douglas A Campbell, Douglas G Ng, Edward P Potter, Edward R Kay, Elizabeth P Kinsella, Elizabeth P Mayer, Emily E Krumel, Erica L Nicoll, Esaw, Evan Kupper, Evan M Kupper, Felipe Rde Almeida, Gale L Glinecki, Genevieve E Ghand, Geoffrey K Kilili, Gess, Gilbert J Heidenblut, Gladys B Casper, Green, Greg K Keshishyan, Gregory E Beichner, Guy W Cartwright, Hamilton, Hamiltonl, Holly J Rapier, Holly J Wilson, Hugh M Mcclure, II, Iqra Iftikhar, James G Marsh, James M Odonnell, Jamie D Richardson, Jason D Werne, Javonica F Penn, Jeffrey A Sincek, Jennifer L Gustavus, Jennifer L Jager, Jennifer M Heitz, Jessica D Weber, Jessica M Monteiro, Jessica M Wooten, Jinkee Mvila Binayug, Jody E Robinson, John D Jaworski, John Dan, John E Russell, John M Seale, Jonathan A Ferguson, Joseph R Hatcher, Joseph X Kaufman, Juan C Gonzalez, Justin B Holder, Karen A Spencer, Karen M Cooper, Katelyn Astaub Zamperini, Kathryn J Mccarty, Keith J Mason, Kelli L Wilkinson, Kelli Wilkinson, Kelsey L Vansickle, Kimberly A Joseph, Klein, Lauren N Smith, LCDR William H Bender, Leslie R Clark, Lisa M Marko, Luckner Jean Marie, Malik S Qaiser, Maney P Sturgill, Margaret H Waters, Marjorie L Davis, Mary B Sheets, Mary E Storch, Mary M Finn, Mary R Kirker, Mastalskij, Matt D Suedkamp, Matthew B Casale, Matthew H Pitts, Matthew R Mcnew, Megan E Kulas, Michael D Thatcher, Michael E Campbell, Michael E Clark, Michael J Diskin, Michael K Larson, Michael L Casner, Mishelle L Harriger, Myrick, Nadeem I Chaudhry, Nancy L Neiger, Nash, Nicholas L Paulin, Payne, Pelekakis, Phillip M Pontikos, Pifer, Raymond W Niles, Renisha M Shaw, Richard F Hapke, Richard W Berning, Rina Bhikha, Rina Vora, Robbie J Alleman, Robert Neligan, Robert P Neligan, Robert Rodriguez, Rosanna M Goodrich, Said H Muse, Seyra Z Hammond, Sherry L Secrist, BLT DO, Slatten, Sonia D Hudson, State Agency, Susan J Essenmacher, Susan M Taylor, Tamara N Champion, Tammy M Phillips, Thomas, Thomas J Hudson, Thomas J Prigge, Thomas W Nojek, Thompsonv, Timothy J Schmidt, Travers, Travis R Hunt, Ucheabuchi C Chudi Nwankwor, Valeria A Moore, William A Warnick, William C Brenneman

Kirk A Dymbrowski's Documents

Publish Date Document Type Title
April, 2012 FDA 483 Response Nat2 Inc - Form 483R, 2012-04-03
May, 2014 EIR Abbott Laboratories - EIR, 2014-05-23
February, 2013 EIR Jeni's Splendid Ice Creams, LLC - EIR, 2013-02-05
May, 2013 EIR Abbott Laboratories - EIR, 2013-05-17
September, 2014 FDA 483 Exclusive Supplements, Inc. - Form 483, 2014-09-16
September, 2013 EIR Abbott Laboratories - EIR, 2013-09-20

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more